Mechanistically, OIP5-AS1 acts as a ceRNA for miR-429, an oncogenic miRNA implicated in several cancers, including breast (Li et al., 2023) and colorectal cancer (Li et al., 2013). This evidence concerns the gene OIP5 and colorectal cancer.